​
​

Evaxion Biotech (EVAX) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChartTranscripts

Evaxion Biotech Revenue Highlights

Latest Revenue (Y)

$73.11K

Latest Revenue (Q)

$50.88K

Evaxion Biotech Revenue by Period

Evaxion Biotech Revenue by Year

DateRevenueChange
2023-12-31$73.11K100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31--

Evaxion Biotech generated $73.11K in revenue during NA 2023, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Evaxion Biotech Revenue by Quarter

DateRevenueChange
2024-03-31$50.88K-30.87%
2023-12-31$73.60K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-11-14-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31--

Evaxion Biotech generated $50.88K in revenue during Q1 2024, up -30.87% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Evaxion Biotech Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
SGTXSigilon Therapeutics$12.94M$5.90M
RVMDRevolution Medicines, Inc. Warrant$11.58M-
UNCYUnicycive Therapeutics$675.00K-
BDRXBiodexa Pharmaceuticals$381.00K$41.50K
LYELLyell Immunopharma$130.00K$34.00K
EVAXEvaxion Biotech$73.11K$50.88K
VRAXVirax Biolabs Group$8.56K$76.50K
CGEMCullinan Oncology--
RVPHReviva Pharmaceuticals--
ZURAZura Bio--
REVBRevelation Biosciences--
PHIOPhio Pharmaceuticals--
GLUEMonte Rosa Therapeutics-$4.70M
ZVSAZyVersa Therapeutics--
ALLRAllarity Therapeutics--
RNAZTransCode Therapeutics--
LABPLandos Biopharma--
EFTReFFECTOR Therapeutics--
QNRXQuoin Pharmaceuticals--

EVAX Revenue FAQ

What is Evaxion Biotech’s yearly revenue?

Evaxion Biotech's yearly revenue for 2023 was $73.11K, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. EVAX's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is Evaxion Biotech’s quarterly revenue?

Evaxion Biotech's quarterly revenue for Q1 2024 was $50.88K, a -30.87% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $73.6K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022). EVAX's quarterly revenue for Q3 2023 was $0, a 100.00% increase from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022).

What is Evaxion Biotech’s revenue growth rate?

Evaxion Biotech's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.